Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-26

Clinical Trial Update: Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis

View source ↗

Summary

A recruiting study under the Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) led by Far Eastern Memorial Hospital to study hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Hypertrophic Cardiomyopathy | Status: RECRUITING